Psychophysical Correlates of Neurodegeneration in Glaucoma
青光眼神经变性的心理物理相关性
基本信息
- 批准号:7923866
- 负责人:
- 金额:$ 48.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-01 至 2013-08-31
- 项目状态:已结题
- 来源:
- 关键词:AdoptedAgeApoptosisAreaBehaviorBehavioralBinocular VisionBlindnessCell DeathCell physiologyClear CellClinicClinicalClinical ManagementDetectionDeteriorationDiagnosticDiseaseEarly treatmentEffectivenessEnvironmentEyeEye MovementsFinancial compensationFunctional disorderGlaucomaHome environmentImpairmentIncidenceInterventionLeadMasksMeasuresModelingMotionMovementNatureNerve DegenerationNoiseOptical Coherence TomographyPatientsPerimetryPeripheralPopulationProcessPsychophysiologyResearchRetinal Ganglion CellsRiskSamplingScotomaScreening procedureSourceStagingSuspect GlaucomasTechniquesTestingVisionVisualVisual FieldsVisual impairmentdesignmonocularmotion sensitivitynovel diagnosticspreventprogramspublic health relevancerelating to nervous systemself diagnosis
项目摘要
DESCRIPTION (provided by applicant): Glaucoma is the second leading cause of blindness in the developed world and causes progressive loss of the peripheral visual field. While visual loss caused by glaucoma is currently irreversible, clinical intervention is most effective if the disease is caught at an early stage, when catastrophic field loss can be averted. Unfortunately existing screening techniques can only detect glaucoma once significant visual impairment has occurred. Although visual deficits in glaucoma are thought to be attributable to programmed cell death (apoptosis) of retinal ganglion cells (RGCs) it is now clear that cell-death is the endpoint of a gradual deterioration in RGC-function. Effective diagnostics cannot wait for cell death, but must measure a behavioral impact of RGC dysfunction. When screening fails, the clinician is particularly reliant on the patients self-diagnosing. Unfortunately more than 50% of people who have diagnosable glaucoma are unaware of it. This, along with poor screening sensitivity has long-term implications for the effective management of an increasingly prevalent disease. This proposal assesses a more efficient and more sensitive motion screening technique that may help detect RGC dysfunction earlier, facilitating prompt clinical intervention to slow the progression of glaucoma. We examine binocular vision, filling-in and compensatory eye movements that may obscure detection of progressive visual impairment and prevent patients from self-diagnosing at an earlier stage of the disease. The overall aim of this proposal is to identify signs of glaucoma that may help bring patients to clinic before catastrophic glaucomatous visual field loss has occurred. Such early intervention allows clinical management of glaucoma to be most effective and so relieves the burden of visual impairment. PUBLIC HEALTH RELEVANCE: Glaucoma is the second leading cause of blindness in the developed world and its incidence is set to rise as the population ages. While visual loss caused by glaucoma is currently irreversible, clinical intervention is most effective if the disease is detected and treated at an early stage, when catastrophic field loss can be averted. The proposed program of research develops new diagnostics that are sensitive to the early stages of neuro-degeneration in glaucoma.
描述(由申请人提供):青光眼是发达国家失明的第二大原因,并导致周边视野逐渐丧失。虽然青光眼引起的视力丧失目前是不可逆转的,但如果在疾病的早期阶段发现这种疾病,临床干预是最有效的,这样可以避免灾难性的视野丧失。不幸的是,现有的筛查技术只能在发生严重视力障碍时检测青光眼。尽管青光眼的视觉缺陷被认为是由视网膜神经节细胞(RGC)的程序性细胞死亡(细胞凋亡)引起的,但现在很清楚,细胞死亡是 RGC 功能逐渐恶化的终点。有效的诊断不能等待细胞死亡,而必须测量 RGC 功能障碍对行为的影响。当筛查失败时,临床医生特别依赖患者的自我诊断。不幸的是,超过 50% 的可诊断青光眼患者并没有意识到这一点。这加上筛查敏感性差,对于有效管理日益流行的疾病具有长期影响。该提案评估了一种更有效、更灵敏的运动筛查技术,该技术可能有助于更早地检测 RGC 功能障碍,从而促进及时的临床干预以减缓青光眼的进展。我们检查双眼视觉、填充和代偿性眼球运动,这些运动可能会掩盖进行性视力障碍的检测,并阻止患者在疾病的早期阶段进行自我诊断。该提案的总体目标是识别青光眼的迹象,这可能有助于在发生灾难性青光眼视野丧失之前将患者带到诊所。这种早期干预可以使青光眼的临床治疗最有效,从而减轻视力障碍的负担。公众健康相关性:青光眼是发达国家第二大失明原因,并且随着人口老龄化,其发病率将会上升。虽然青光眼引起的视力丧失目前是不可逆转的,但如果在早期发现并治疗该疾病,则临床干预是最有效的,这样可以避免灾难性的视野丧失。拟议的研究计划开发了对青光眼神经变性早期阶段敏感的新诊断方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Peter John Bex其他文献
Peter John Bex的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Peter John Bex', 18)}}的其他基金
ARBi - Assessment and Rehabilitation of Binocular Sensorimotor Disorders
ARBi - 双眼感觉运动障碍的评估和康复
- 批准号:
10559543 - 财政年份:2022
- 资助金额:
$ 48.22万 - 项目类别:
Eye Movement Rehabilitation in Low Vision Patients
低视力患者的眼动康复
- 批准号:
10612338 - 财政年份:2019
- 资助金额:
$ 48.22万 - 项目类别:
Eye Movement Rehabilitation in Low Vision Patients
低视力患者的眼动康复
- 批准号:
10362666 - 财政年份:2019
- 资助金额:
$ 48.22万 - 项目类别:
Enhancement of Dynamic Media for Visually-Impaired People
为视障人士增强动态媒体
- 批准号:
7923865 - 财政年份:2009
- 资助金额:
$ 48.22万 - 项目类别:
Enhancement of Dynamic Media for Visually-Impaired People
为视障人士增强动态媒体
- 批准号:
7737272 - 财政年份:2009
- 资助金额:
$ 48.22万 - 项目类别:
Psychophysical Correlates of Neurodegeneration in Glaucoma
青光眼神经变性的心理物理相关性
- 批准号:
7731888 - 财政年份:2009
- 资助金额:
$ 48.22万 - 项目类别:
Enhancement of Dynamic Media for Visually-Impaired People
为视障人士增强动态媒体
- 批准号:
8320302 - 财政年份:2009
- 资助金额:
$ 48.22万 - 项目类别:
Enhancement of Dynamic Media for Visually-Impaired People
为视障人士增强动态媒体
- 批准号:
8136081 - 财政年份:2009
- 资助金额:
$ 48.22万 - 项目类别:
Psychophysical Correlates of Neurodegeneration in Glaucoma
青光眼神经变性的心理物理相关性
- 批准号:
8320306 - 财政年份:2009
- 资助金额:
$ 48.22万 - 项目类别:
Psychophysical Correlates of Neurodegeneration in Glaucoma
青光眼神经变性的心理物理相关性
- 批准号:
8132907 - 财政年份:2009
- 资助金额:
$ 48.22万 - 项目类别:
相似国自然基金
EGCG在氧化损伤诱导晶状体上皮细胞中的抑凋亡机理及对年龄相关性白内障缓解作用的相关研究
- 批准号:82271070
- 批准年份:2022
- 资助金额:50 万元
- 项目类别:面上项目
一氧化碳释放分子-3(CORM-3)通过抑制晶状体上皮细胞凋亡对年龄相关性白内障治疗作用机制的研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
转录因子E2F1在年龄相关性听力损失中的作用及机制研究
- 批准号:81700911
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
XBP1对视网膜色素上皮细胞Nrf2信号通路的调控及其对细胞凋亡的保护作用
- 批准号:81660167
- 批准年份:2016
- 资助金额:39.0 万元
- 项目类别:地区科学基金项目
Calb1在年龄相关性白内障发生过程中的作用机制研究
- 批准号:81560160
- 批准年份:2015
- 资助金额:37.0 万元
- 项目类别:地区科学基金项目
相似海外基金
The Neuronal Effect of CHI3L1 in Neuroinflammation & Alzheimer's Disease
CHI3L1 在神经炎症中的神经元作用
- 批准号:
10679915 - 财政年份:2023
- 资助金额:
$ 48.22万 - 项目类别:
MET kinase fusions in pediatric glioblastoma
儿童胶质母细胞瘤中的 MET 激酶融合
- 批准号:
10690229 - 财政年份:2022
- 资助金额:
$ 48.22万 - 项目类别: